CareTrust REIT (NYSE:CTRE) Rating Increased to Strong-Buy at UBS Group

CareTrust REIT (NYSE:CTRE) was upgraded by UBS Group to a “strong-buy” rating in a note issued to investors on Tuesday,Zacks.com reports.

A number of other equities research analysts have also issued reports on the stock. Weiss Ratings restated a “buy (b)” rating on shares of CareTrust REIT in a report on Wednesday, October 8th. Cantor Fitzgerald upgraded shares of CareTrust REIT to a “hold” rating in a research report on Wednesday, October 1st. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Buy”.

CareTrust REIT Stock Up 1.6%

Shares of NYSE CTRE opened at $36.96 on Tuesday. The company has a debt-to-equity ratio of 0.22, a quick ratio of 6.98 and a current ratio of 6.98. CareTrust REIT has a 12 month low of $24.79 and a 12 month high of $37.19. The stock has a market capitalization of $8.25 billion, a P/E ratio of 27.58, a price-to-earnings-growth ratio of 1.42 and a beta of 0.81. The company’s fifty day moving average is $34.81.

CareTrust REIT (NYSE:CTRE) last issued its quarterly earnings results on Wednesday, November 5th. The company reported $0.35 earnings per share for the quarter. CareTrust REIT had a return on equity of 7.95% and a net margin of 61.00%.The firm had revenue of $132.44 million for the quarter.

CareTrust REIT Company Profile

CareTrust REIT, Inc is a self-administered, publicly-traded real estate investment trust engaged in the ownership, acquisition, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. With a nationwide portfolio of long-term net-leased properties, and a growing portfolio of quality operators leasing them, CareTrust REIT is pursuing both external and organic growth opportunities across the United States.